Skip to main content
. 2015 Jun 8;10(6):e0129969. doi: 10.1371/journal.pone.0129969

Table 2. Main characteristics of the included studies.

Study Intervention
Control Treatment
Deng K 2010 Aspirin 100 mg/d, Low molecular heparin sodium 4000 IU/d, Metoprolol 25 mg/d, Simvastatin 20 mg/d, Nitroglycerin 0.3–0.6 mg /d. Aspirin 100 mg/d, Low molecular heparin sodium 4000 IU/d, Metoprolol 25 mg/d, Simvastatin 20 mg/d, Nitroglycerin 0.3–0.6 mg/d; Breviscapine injection (50 mg/d)
Hu S 2011 Calcium channel blocker, β-blocker, Oxygen Inhalation Calcium channel blocker, β-blocker, Oxygen Inhalation; Breviscapine injection (50 mg/d)
Li HP 2011 Isosorbide Mononitrate 40 mg/d, Aspirin 75 mg/d, Metoprolol 25 mg/d, Simvastatin 20 mg/d Isosorbide Mononitrate 40 mg/d, Aspirin 75 mg/d, Metoprolol 25 mg/d, Simvastatin 20 mg/d; Breviscapine injection (40 mg/d)
Liang TH 2010 Nitroglycerin 10 mg/d, Aspirin 75 mg/d Nitroglycerin 10 mg/d, Aspirin 75 mg/d; Breviscapine injection (30 mg/d)
Lu YJ 2010 Nitroglycerin, Aspirin, β-blocker, ACEI Nitroglycerin, Aspirin, β-blocker, ACEI; Breviscapine injection (50 mg/d)
Meng LC 2012 Aspirin 100 mg/d, Low molecular heparin sodium 5000 IU/d, Metoprolol 50 mg/d, Atorvastatin 20 mg/d Aspirin 100 mg/d, Low molecular heparin sodium 5000 IU/d, Metoprolol 50 mg/d, Atorvastatin 20 mg/d; Breviscapine injection (40 mg/d)
Peng DY 2011 Isosorbide dinitrate 5–20 mg/d, Lipid-lowering, antihypertensive, hypoglycemic treatment Isosorbide dinitrate 5–20 mg/d, Lipid-lowering, antihypertensive, hypoglycemic treatment; Breviscapine injection (50 mg/d)
Shao ZB 2009 Aspirin, nitrates, Low molecular heparin sodium, Statin Aspirin, nitrates, Low molecular heparin sodium, Statin; Breviscapine injection (100 mg/d)
Shi SH 2011 Aspirin, Calcium channel blocker, β-blocker, ACEI, Nitrates Aspirin, Calcium channel blocker, β-blocker, ACEI, Nitrates; Breviscapine injection (50 mg/d)
Tan ZH 2009 Nitroglycerin 5 mg/d, Calcium channel blocker, β-blocker Nitroglycerin 5 mg/d, Calcium channel blocker, β-blocker; Breviscapine injection (25 mg/d)
Xu XR 2006 β-blocker, Dual anti-platelet therapy, vasodilator therapy β-blocker, Dual anti-platelet therapy, vasodilator therapy; Breviscapine injection (20 mg/d)
Yu HW 2001 Aspirin, Nitroglycerin, Isosorbide dinitrate Aspirin, Nitroglycerin, Isosorbide dinitrate; Breviscapine injection (100 mg/d)
Zhang QM 2012 Aspirin, β-blocker, ACEI, Nitrates, Lipid drugs Aspirin, β-blocker, ACEI, Nitrates, Lipid drugs; Breviscapine injection (40 mg/d)
Zhang XD 2011 Aspirin, Nitrates, Low molecular heparin sodium, Statin Aspirin, Nitrates, Low molecular heparin sodium, Statin; Breviscapine injection (30 mg/d)
Zhao JG 2010 Aspirin 100 mg/d, Low molecular heparin sodium Aspirin 100 mg/d, Low molecular heparin sodium; Breviscapine injection (100 mg/d)
Zhou BX 2007 Aspirin, nitrates, Dual anti-platelet therapy Aspirin, nitrates, Dual anti-platelet therapy; Breviscapine injection (50 mg/d)